comparemela.com

Latest Breaking News On - Quantbiome inc - Page 1 : comparemela.com

Human Microbiome Market worth $1.7 billion by 2029 - Ucommune International (NASDAQ:UK)

"The Asian market has garnered significant attention from global players due to the increased focus on preventative healthcare and personalized medicine, driving the demand for human microbiomes."Human Microbiome Market

Visp
Switzerland-general
Switzerland
United-kingdom
United-states
Asia-pacific
Aashish-mehra
Seres-therapeutics-inc
Viome-life-sciences-inc
Flightpath-biosciences-inc
Optibiotix-health
Research-private-ltd

Global Human Microbiome Market Report 2023: Sector is Projected to Reach $1.7 Billion by 2029 at a CAGR of 36.1%

/PRNewswire/ The "Global Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer,.

Dublin
Ireland
United-states
America
Atlas-biomed
Laura-wood
Vedanta-biosciences-inc
Seed-health
Viome-life-sciences-inc
Seres-therapeutics-inc
Bione-ventures-private
Office-hours-call

Global Human Microbiome Market Report to 2029: Rising

Dublin, June 06, 2023 (GLOBE NEWSWIRE) The "Global Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic,.

Dublin
Ireland
United-states
America
Atlas-biomed
Academia-for-microbiome-research
Seed-health
Seres-therapeutics-inc
Quantbiome-inc
Bione-ventures-private
Ferring-pharmaceuticals
Second-genome-inc

Human Microbiome Market worth $1.7 billion | MarketsandMarkets

/PRNewswire/ The human microbiome industry is poised for exponential growth and transformative advancements in the near future. As our understanding of the.

Chicago
Illinois
United-states
Northbrook
Visp
Switzerland-general
Switzerland
United-kingdom
America
Aashish-mehra
Asia-pacific
Laboratory-proficiency-testing-market

Global Human Microbiome Markets, 2021-2028 - Opportunities in Increasing Collaborations Between Public-Private Organizations

Share this article Share this article ResearchAndMarkets.com s offering. The global human microbiome market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025, at a CAGR of 21.3% from 2025 to 2028. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development & development of human microbiome-based tests for early disease detection and diagnosis are also factors expected to support market growth. However, a lack of expertise and inadequate research on the human microbiome are factors expected to restrain this market s growth.

United-states
United-kingdom
Dublin
Ireland
Switzerland
America
American
Laura-wood
Atlas-biomed-group
Evelo-biosciences-inc
Optibiotix-health-united-kingdom
Vithera-pharmaceuticals

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.